Pharmacists' knowledge, attitudes, and practices regarding influenza vaccination and treatment of pregnant women

Journal of the American Pharmacists Association

Volumn 52, Issue 1, 2012, Pages 43-56

  Dolan, Siobhan M ^a   Cox, Shanna ^b   Tepper, Naomi ^c   Ruddy, Deborah ^e   Rasmussen, Sonja A ^d   MacFarlane, Kitty ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^e NONE

Author keywords

H1N1 influenza; Influenza; Pregnancy; Vaccinations

Indexed keywords

INFLUENZA VACCINE; OSELTAMIVIR; PARACETAMOL;

2009 H1N1 INFLUENZA; ARTICLE; DESCRIPTIVE RESEARCH; EDUCATION PROGRAM; EXPLORATORY RESEARCH; FEMALE; HUMAN; INFLUENZA VACCINATION; MALE; MEDICAL ASSESSMENT; MEDICAL EDUCATION; OBSERVATIONAL STUDY; PHARMACIST; PHARMACIST ATTITUDE; PREGNANT WOMAN; PROFESSIONAL KNOWLEDGE; PROFESSIONAL PRACTICE; SEASONAL INFLUENZA; SEX DIFFERENCE; UNITED STATES; ATTITUDE TO HEALTH; CERTIFICATION; EDUCATION; HEALTH CARE ORGANIZATION; HEALTH CARE SURVEY; INFLUENZA; INFLUENZA VIRUS A H1N1; ORGANIZATION AND MANAGEMENT; PREGNANCY; PREGNANCY COMPLICATION; RISK; VIROLOGY;

CERTIFICATION; EDUCATION, PHARMACY, CONTINUING; FEMALE; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; PHARMACISTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK; SOCIETIES, PHARMACEUTICAL; UNITED STATES;

EID: 84861203941     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2012.10141     Document Type: Article

References (44)

1. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, Dawood FS, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009;360:2605-15.
2. Siston AM, Rasmussen SA, Honein MA, et al. Pandemic 2009 influenza A (H1N1) virus illness among pregnant women in the United States. JAMA. 2010;303:1517-25.
3. Centers for Disease Control and Prevention. 2009 pandemic influenza A (H1N1) in pregnant women requiring intensive care: New York City, 2009. MMWR Morb Mortal Wkly Rep. 2010;59:321-6.
4. Dodds L, McNeil SA, Fell DB, et al. Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. CMAJ. 2007;176:463-8.
5. Jamieson DJ, Honein MA, Rasmussen SA, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet. 2009;374:451-8.
6. Neuzil KM, Reed GW, Mitchel EF, et al. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol. 1998;148:1094-102.
7. Rasmussen SA, Jamieson DJ, Bresee JS. Pandemic influenza and pregnant women. Emerg Infect Dis. 2008;14:95-100.
8. Centers for Disease Control and Prevention. H1N1 flu (swine flu): resources for obstetric health care providers. Accessed at http://cdc.gov/ h1n1flu/clinician-pregnant.htm, June 6, 2010.
9. Fiore AE, Shay DK, Broder K, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep. 2008;57(RR-7):1-60.
10. Centers for Disease Control and Prevention (CDC). Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep. 2009;58(RR-10):1-8.
11. ACOG Committee on Obstetric Practice. ACOG committee opinion number 305, November 2004: influenza vaccination and treatment during pregnancy. Obstet Gynecol. 2004;104:1125-6.
12. Lu P, Bridges CB, Euler GL, Singleton JA. Influenza vaccination of recommended adult populations, U.S., 1989-2005. Vaccine. 2008;26:1786-93.
13. Zaman K, Roy E, Arifeen SE, et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med. 2008;359:1555-64.
14. Tamma PD, Ault KA, del Rio C, et al. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol. 2009;201:547-52.
15. Ayoub DM, Yazbak FE. A closer look at influenza vaccination during pregnancy. Lancet Infect Dis. 2008;8:660-1.
16. Lo WY, Friedman JM. Teratogenicity of recently introduced medications in human pregnancy. Obstet Gynecol. 2002;100:465-73.
17. Rasmussen SA, Jamieson DJ, Macfarlane K, et al. Pandemic influenza and pregnant women: summary of a meeting of experts. Am J Public Health. 2009;99(suppl 2):S248-54.
18. Tanaka T, Nakajima K, Murashima A, et al. Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women. CMAJ. 2009;181:55-8.
19. Greer LG, Abbassi-Ghanavati M, Sheffield JS, Casey BM. Diagnostic dilemmas in a pregnant woman with influenza A (H1N1) infection. 2010;115:409-12.
20. Centers for Disease Control and Prevention (CDC). CDC Health Alert Network (HAN) Info Service Message: recommendations for early empiric antiviral treatment in persons with suspected influenza who are at increased risk of developing severe disease. Accessed at www.cdc.gov/H1N1flu/HAN/101909.htm, June 6, 2010.
21. Centers for Disease Control and Prevention. Novel influenza A (H1N1) virus infections in three pregnant women: United States, April-May 2009. MMWR Morb Mortal Wkly Rep. 2009;58:497-500.
22. Louie JK, Acosta M, Jamieson DJ, et al. Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med. 2010;362:27-35.
23. American Society of Health-System Pharmacists Council on Professional Affairs. ASHP guidelines on the pharmacist's role in immunization. Am J Health Syst Pharm. 2003;60:1371-7.
24. Hogue MD, Grabenstein JD, Foster SL, Rothholz MC. Pharmacist involvement with immunizations: a decade of professional advancement. J Am Pharm Assoc. 2006;46:168-79.
25. Grabenstein JD. Pharmacists as vaccine advocates: roles in community pharmacies, nursing homes, and hospitals. Vaccine. 1998;16:1705-10.
26. Bounthavong M, Christopher ML, Mendes MA, et al. Measuring patient satisfaction in the pharmacy specialty immunization clinic: a pharmacist-run Immunization Clinic at the Veterans Affairs San Diego Healthcare System. Int J Pharm Pract. 2010;18:100-7.
27. Kamal KM, Madhavan SS, Maine LL. Pharmacy and immunization services: pharmacists' participation and impact. J Am Pharm Assoc. 2003;43:470-82.
28. American Pharmacists Association. Pharmacy-based immunization delivery. Accessed at www.pharmacist.com/Content/NavigationMenu3/ContinuingEducation/ CertificateTrainingProgram/PharmacyBasedImmunizationDelivery/ Pharmacy-Based-Immun.htm, May 27, 2010.
29. Census Bureau. Census 2000 geographic definitions: introduction: geographic presentation of data. Accessed at www.census.gov/geo/www/geo-defn. html, May 27, 2010.
30. SteelFisher GK, Blendon RJ, Bekheit MM, Lubell K. The public's response to the 2009 H1N1 influenza pandemic. N Engl J Med. 2010;362:e65.
31. Centers for Disease Control and Prevention. Vaccine safety. Accessed at www.cdc.gov/h1n1flu/vaccination/vaccine-safety.htm, June 6, 2010.
32. Centers for Disease Control and Prevention. Safety of influenza A (H1N1) 2009 monovalent vaccines: United States, October 1-November 24, 2009. MMWR Morb Mortal Wkly Rep. 2009;58:1351-6.
33. Moro PL, Broder, K, Zheteyeva Y, et al. Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System. Am J Obstet Gynecol. 2011;205:473.e1-9.
34. Department of Health & Human Services. Coverage under the Public Readiness and Emergency Preparedness (PREP) Act for H1N1 Vaccination. Accessed at www.flu.gov/professional/federal/vaccineliability.html, June 6, 2010.
35. Centers for Disease Control and Prevention. Update: influenza activity: United States, August 30, 2009-March 27, 2010, and composition of the 2010-11 influenza vaccine. MMWR Morb Mortal Wkly Rep. 2010;59:423-30.
36. Centers for Disease Control and Prevention. Questions and answers on 2009 H1N1 vaccine financing. Accessed at www.cdc.gov/H1N1flu/vaccination/statelocal/ vaccine-financing.htm, June 6, 2010.
37. Centers for Disease Control and Prevention. 2009 H1N1 vaccine doses allocated, ordered, and shipped by project area. Accessed at www.cdc.gov/h1n1flu/vaccination/vaccinesupply.htm, June 28, 2010.
38. Williams JL, Abelman SM, Fassett EM, et al. Health care provider knowledge and practices regarding folic acid, United States, 2002-2003. Matern Child Health J. 2006;10(5 suppl):S67-72.
39. Couzin-Frankel J. Drug safety: new network to track drugs and vaccines in pregnancy. Science. 2010;327:1066-7.
40. Morgan MA, Cragan JD, Goldenberg RL, et al. Obstetrician-gynaecologist knowledge of and access to information about the risks of medication use during pregnancy. J Matern Fetal Neonatal Med. 2010;23:1143-50.
41. Feibus KB. FDA's proposed rule for pregnancy and lactation labeling: improving maternal child health through well-informed medicine use. J Med Toxicol. 2008;4:284-8.
42. Midwest Pharmacy Workforce Research Consortium. 2009 National Pharmacist Workforce Survey. Accessed at www.aacp.org/resources/research/pharmacymanpower/ Documents/2009%20National%20Pharmacist%20Workforce%20Survey%20- %20FINAL%20REPORT.pdf, June 6, 2010.
43. American College of Obstetricians and Gynecologists Committee on Obstetric Practice. ACOG Committee Opinion no. 468: influenza vaccination during pregnancy. Obstet Gynecol. 2010;116:1006-7.
44. Centers for Disease Control and Prevention. Interim results: influenza A (H1N1) 2009 monovalent vaccination coverage: United States, October-December 2009. MMWR Morb Mortal Wkly Rep. 2010;59:44-8.